US Stock MarketDetailed Quotes

PDSB PDS Biotechnology

Watchlist
  • 1.550
  • +0.040+2.65%
Close Jan 24 16:00 ET
  • 1.550
  • 0.0000.00%
Post 20:01 ET
57.98MMarket Cap-1.32P/E (TTM)

PDS Biotechnology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11.48%-8M
-83.99%-8.86M
24.65%-9.94M
-30.83%-33.64M
-12.33%-8.46M
-21.77%-7.18M
18.66%-4.81M
-107.08%-13.19M
-105.91%-25.71M
-67.26%-7.53M
Net income from continuing operations
1.13%-10.73M
27.80%-8.33M
-9.77%-10.6M
-5.11%-42.94M
43.05%-10.9M
-46.13%-10.85M
-98.22%-11.53M
-14.00%-9.66M
-141.48%-40.85M
-202.81%-19.14M
Depreciation and amortization
15.36%5.46K
15.27%5.46K
50.08%4.74K
20,084.88%17.36K
--4.74K
--4.73K
--4.74K
3,568.60%3.16K
-98.39%86
--0
Other non cash items
51.17%314.8K
-29.19%560.44K
44.87%279.91K
-65.77%1.87M
-86.87%680.76K
22.21%208.24K
1,213.46%791.45K
220.64%193.21K
2,171.05%5.47M
8,501.65%5.18M
Change In working capital
-54.68%628.44K
-175.72%-2.89M
78.48%-1.25M
-104.45%-199.28K
-92.07%400.69K
8,154.92%1.39M
353.15%3.82M
-734.33%-5.81M
5,802.27%4.47M
5,922.16%5.05M
-Change in prepaid assets
-65.67%47.69K
-883.69%-376.4K
489.61%443.21K
115.59%165.67K
-14.91%92.47K
1,363.49%138.93K
105.29%48.03K
54.83%-113.76K
-963.68%-1.06M
14,418.31%108.68K
-Change in payables and accrued expense
-55.60%580.75K
-165.15%-2.52M
69.79%-1.69M
-102.08%-125.48K
-93.92%308.23K
359.00%1.31M
833.62%3.86M
-562.99%-5.6M
1,641.65%6.04M
3,868.72%5.07M
-Change in other current assets
----
----
----
--0
----
----
----
----
---423.88K
---117.39K
-Change in other current liabilities
--0
--0
--0
-222.03%-239.47K
--0
-222.38%-60.33K
-22.08%-90.03K
-107.04%-89.1K
56.47%-74.36K
84.01%-6.88K
Cash from discontinued investing activities
Operating cash flow
-11.48%-8M
-83.99%-8.86M
24.65%-9.94M
-30.83%-33.64M
-12.33%-8.46M
-21.77%-7.18M
18.66%-4.81M
-107.08%-13.19M
-105.91%-25.71M
-67.26%-7.53M
Investing cash flow
Cash flow from continuing investing activities
-1
0
Net PPE purchase and sale
---1
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
---1
----
----
----
----
--0
----
----
----
----
Financing cash flow
Cash flow from continuing financing activities
-97.85%17.22K
-105.74%-13.79K
338.11%20.01M
-52.24%16.38M
10.92%10.77M
-96.73%802.33K
970.07%240.01K
60,902.34%4.57M
-29.87%34.29M
74,666,484.62%9.71M
Net issuance payments of debt
-9.54%-14.11K
-9.53%-13.79K
34.80%-13.48K
-100.24%-59.3K
---13.17K
-100.05%-12.88K
---12.59K
---20.67K
--25M
--0
Net common stock issuance
-108.24%-67.18K
--0
324.85%19.49M
63.62%16.13M
6.32%10.48M
--815.2K
--243.74K
--4.59M
-79.70%9.86M
--9.86M
Proceeds from stock option exercised by employees
--98.5K
--0
--531.09K
104.04%308.94K
146.99%300.09K
--0
-60.55%8.85K
--0
-56.00%151.42K
934,507.69%121.5K
Net other financing activities
----
----
----
----
----
----
----
----
---720.29K
---270.96K
Cash from discontinued financing activities
Financing cash flow
-97.85%17.22K
-105.74%-13.79K
338.11%20.01M
-52.24%16.38M
10.92%10.77M
-96.73%802.33K
970.07%240.01K
60,902.34%4.57M
-29.87%34.29M
74,666,484.62%9.71M
Net cash flow
Beginning cash position
-4.77%57.73M
2.20%66.63M
-23.38%56.56M
13.15%73.82M
-24.27%54.25M
14.42%60.62M
10.73%65.2M
13.15%73.82M
126.23%65.24M
2.72%71.64M
Current changes in cash
-25.24%-7.98M
-94.58%-8.9M
216.86%10.07M
-301.22%-17.26M
6.03%2.31M
-134.16%-6.37M
22.42%-4.57M
-35.51%-8.62M
-76.44%8.58M
148.38%2.18M
End cash Position
-8.29%49.75M
-4.77%57.73M
2.20%66.63M
-23.38%56.56M
-23.38%56.56M
-24.27%54.25M
14.42%60.62M
10.73%65.2M
13.15%73.82M
13.15%73.82M
Free cash flow
-11.48%-8M
-84.59%-8.89M
24.65%-9.94M
-30.83%-33.64M
-12.33%-8.46M
-21.77%-7.18M
18.66%-4.81M
-107.08%-13.19M
-105.91%-25.71M
-67.26%-7.53M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11.48%-8M-83.99%-8.86M24.65%-9.94M-30.83%-33.64M-12.33%-8.46M-21.77%-7.18M18.66%-4.81M-107.08%-13.19M-105.91%-25.71M-67.26%-7.53M
Net income from continuing operations 1.13%-10.73M27.80%-8.33M-9.77%-10.6M-5.11%-42.94M43.05%-10.9M-46.13%-10.85M-98.22%-11.53M-14.00%-9.66M-141.48%-40.85M-202.81%-19.14M
Depreciation and amortization 15.36%5.46K15.27%5.46K50.08%4.74K20,084.88%17.36K--4.74K--4.73K--4.74K3,568.60%3.16K-98.39%86--0
Other non cash items 51.17%314.8K-29.19%560.44K44.87%279.91K-65.77%1.87M-86.87%680.76K22.21%208.24K1,213.46%791.45K220.64%193.21K2,171.05%5.47M8,501.65%5.18M
Change In working capital -54.68%628.44K-175.72%-2.89M78.48%-1.25M-104.45%-199.28K-92.07%400.69K8,154.92%1.39M353.15%3.82M-734.33%-5.81M5,802.27%4.47M5,922.16%5.05M
-Change in prepaid assets -65.67%47.69K-883.69%-376.4K489.61%443.21K115.59%165.67K-14.91%92.47K1,363.49%138.93K105.29%48.03K54.83%-113.76K-963.68%-1.06M14,418.31%108.68K
-Change in payables and accrued expense -55.60%580.75K-165.15%-2.52M69.79%-1.69M-102.08%-125.48K-93.92%308.23K359.00%1.31M833.62%3.86M-562.99%-5.6M1,641.65%6.04M3,868.72%5.07M
-Change in other current assets --------------0-------------------423.88K---117.39K
-Change in other current liabilities --0--0--0-222.03%-239.47K--0-222.38%-60.33K-22.08%-90.03K-107.04%-89.1K56.47%-74.36K84.01%-6.88K
Cash from discontinued investing activities
Operating cash flow -11.48%-8M-83.99%-8.86M24.65%-9.94M-30.83%-33.64M-12.33%-8.46M-21.77%-7.18M18.66%-4.81M-107.08%-13.19M-105.91%-25.71M-67.26%-7.53M
Investing cash flow
Cash flow from continuing investing activities -10
Net PPE purchase and sale ---1------------------0----------------
Cash from discontinued investing activities
Investing cash flow ---1------------------0----------------
Financing cash flow
Cash flow from continuing financing activities -97.85%17.22K-105.74%-13.79K338.11%20.01M-52.24%16.38M10.92%10.77M-96.73%802.33K970.07%240.01K60,902.34%4.57M-29.87%34.29M74,666,484.62%9.71M
Net issuance payments of debt -9.54%-14.11K-9.53%-13.79K34.80%-13.48K-100.24%-59.3K---13.17K-100.05%-12.88K---12.59K---20.67K--25M--0
Net common stock issuance -108.24%-67.18K--0324.85%19.49M63.62%16.13M6.32%10.48M--815.2K--243.74K--4.59M-79.70%9.86M--9.86M
Proceeds from stock option exercised by employees --98.5K--0--531.09K104.04%308.94K146.99%300.09K--0-60.55%8.85K--0-56.00%151.42K934,507.69%121.5K
Net other financing activities -----------------------------------720.29K---270.96K
Cash from discontinued financing activities
Financing cash flow -97.85%17.22K-105.74%-13.79K338.11%20.01M-52.24%16.38M10.92%10.77M-96.73%802.33K970.07%240.01K60,902.34%4.57M-29.87%34.29M74,666,484.62%9.71M
Net cash flow
Beginning cash position -4.77%57.73M2.20%66.63M-23.38%56.56M13.15%73.82M-24.27%54.25M14.42%60.62M10.73%65.2M13.15%73.82M126.23%65.24M2.72%71.64M
Current changes in cash -25.24%-7.98M-94.58%-8.9M216.86%10.07M-301.22%-17.26M6.03%2.31M-134.16%-6.37M22.42%-4.57M-35.51%-8.62M-76.44%8.58M148.38%2.18M
End cash Position -8.29%49.75M-4.77%57.73M2.20%66.63M-23.38%56.56M-23.38%56.56M-24.27%54.25M14.42%60.62M10.73%65.2M13.15%73.82M13.15%73.82M
Free cash flow -11.48%-8M-84.59%-8.89M24.65%-9.94M-30.83%-33.64M-12.33%-8.46M-21.77%-7.18M18.66%-4.81M-107.08%-13.19M-105.91%-25.71M-67.26%-7.53M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending Stocks
Donald Trump Donald Trump

Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.